We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+2.94%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.5B
AUM Growth
-$26.3M
Cap. Flow
-$36.9M
Cap. Flow %
-0.82%
Top 10 Hldgs %
8.67%
Holding
752
New
65
Increased
220
Reduced
377
Closed
83

Top Buys

Rank Stock Value
1
BOOT icon
Boot Barn
BOOT
+$17.2M
2
UPBD icon
Upbound Group
UPBD
+$10.9M
3
MRCY icon
Mercury Systems
MRCY
+$10.6M
4
KMPR icon
Kemper
KMPR
+$9.56M
5
ESAB icon
ESAB
ESAB
+$8.84M

Sector Composition

Rank Sector Weight
1 Financials 20.83%
2 Industrials 18.44%
3 Healthcare 17.49%
4 Technology 13.76%
5 Consumer Discretionary 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWD icon
551
Woodward
WWD
$21B
$1.56M 0.03%
+9,349
New +$1.6M
MX icon
552
Magnachip Semiconductor
MX
$134M
$1.54M 0.03%
383,989
+7,091
+2% +$30.2K
NVS icon
553
Novartis
NVS
$298B
$1.54M 0.03%
+15,840
New +$1.69M
CRDO icon
554
Credo Technology Group
CRDO
$44.7B
$1.51M 0.03%
22,504
-9,825
-30% -$488K
TWI icon
555
Titan International
TWI
$457M
$1.48M 0.03%
+218,201
New +$1.57M
OPRT icon
556
Oportun Financial
OPRT
$356M
$1.45M 0.03%
374,863
+29,096
+8% +$93.8K
OVID icon
557
Ovid Therapeutics
OVID
$489M
$1.44M 0.03%
1,545,387
+17,402
+1% +$19.5K
ARAY icon
558
Accuray
ARAY
$34.9M
$1.43M 0.03%
723,438
-41,495
-5% -$78.5K
NE icon
559
Noble Corp
NE
$6.95B
$1.42M 0.03%
45,371
-1,499
-3% -$49.6K
SLRN
560
DELISTED
ACELYRIN
SLRN
$1.4M 0.03%
446,850
-5,920
-1% -$28.7K
ABUS icon
561
Arbutus Biopharma
ABUS
$907M
$1.38M 0.03%
420,709
+804
+0.2% +$2.96K
PCVX icon
562
Vaxcyte
PCVX
$8.67B
$1.35M 0.03%
+16,526
New +$1.64M
CGEM icon
563
Cullinan Oncology
CGEM
$1.18B
$1.35M 0.03%
+111,049
New +$1.6M
DVAX
564
DELISTED
Dynavax Technologies
DVAX
$1.35M 0.03%
105,687
-2,998
-3% -$36.3K
NPKI
565
NPK International
NPKI
$1.15B
$1.33M 0.03%
173,841
-4,449
-2% -$32.7K
MDRX
566
DELISTED
Veradigm Inc. Common Stock
MDRX
$1.33M 0.03%
136,616
-1,634
-1% -$15.9K
HURC icon
567
Hurco Companies Inc
HURC
$141M
$1.33M 0.03%
68,861
-1,918
-3% -$40.4K
QIPT
568
DELISTED
Quipt Home Medical
QIPT
$1.31M 0.03%
429,917
-524,819
-55% -$1.41M
TWIN icon
569
Twin Disc
TWIN
$342M
$1.31M 0.03%
111,514
-2,853
-2% -$34.1K
SWIM icon
570
Latham Group
SWIM
$860M
$1.3M 0.03%
+186,145
New +$1.24M
AIOT
571
PowerFleet Inc
AIOT
$411M
$1.27M 0.03%
191,090
+15,352
+9% +$92.1K
NREF
572
NexPoint Real Estate Finance
NREF
$322M
$1.27M 0.03%
80,913
-77,321
-49% -$1.24M
SAFE
573
Safehold
SAFE
$1.09B
$1.26M 0.03%
68,436
-1,791
-3% -$38.9K
ACEL icon
574
Accel Entertainment
ACEL
$978M
$1.26M 0.03%
118,151
-3,430
-3% -$39.2K
ARKO icon
575
ARKO Corp
ARKO
$527M
$1.25M 0.03%
189,148
-5,392
-3% -$37.1K

Similar funds

Kennedy Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Kennedy Capital Management held 752 positions worth $4.5B, down 0.58% from $4.53B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Kennedy Capital Management's Q4 2024 filing shows 65 new, 220 increased, 377 reduced and 83 closed positions. Its largest new stake was Boot Barn: 116,357 shares worth $17.7M. The largest sale was Stifel, an estimated $19.5M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

  • Kennedy Capital Management's largest Q4 2024 buy was Boot Barn: 116,357 shares worth $17.7M.
  • Kennedy Capital Management added most to Mercury Systems in Q4 2024, an estimated $10.6M increase.
  • Kennedy Capital Management's biggest Q4 2024 reduction was Stifel, cutting an estimated $19.5M.
  • Kennedy Capital Management fully exited Phathom Pharmaceuticals in Q4 2024, selling an estimated $13.2M.
  • Kennedy Capital Management's ten largest holdings make up 8.7% of its $4.5B portfolio in Q4 2024.
  • Kennedy Capital Management opened 65 new positions and closed 83 in Q4 2024.
  • Kennedy Capital Management's portfolio value fell 0.58% quarter-over-quarter to $4.5B.

Based on Kennedy Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.